Coloplast A/S (OTC Pink - Limited Information:CLPBY)
| 10.76 Delayed Data As of Sep 22 |  -0.13 / -1.19%Today’s Change | 9.58 Today|||52-Week Range 14.77 | -7.48% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $20.9B |
Company Description
Coloplast A/S develops, manufactures, and markets medical products. It operates through the following segments: Chronic Care, Interventional Urology and Wound & Skin Care. The Chronic Care segment covers the sale of ostomy care products and continence care products. The Interventional Urology segment covers the sale of urological products, including disposable products. The Wound & Skin Care segment covers the sale of wound and skin care products. The company was founded by Aage Louis-Hansen and Johanne Louise-Hansen in 1954 and is headquartered in Humlebaek, Denmark.
Contact Information
Coloplast A/S Holtedam 1-3 Humlebaek Zealand 3050 |
Employees
Shareholders
| Other institutional | 0.02% |
| Mutual fund holders | 0.00% |
| Individual stakeholders | -- |
Top Executives
| Kristian Villumsen | President & Chief Executive Officer |
| Allan Rasmussen | Executive Vice President-Global Operations |
| Anders Lonning-Skovgaard | Chief Financial Officer & Executive Vice President |
| Thomas Barfod | Director & Controller |
| Paul Marcun | Executive Vice President-Growth |
